Martijn Cox
Fondateur chez Xeltis AG
Profil
Martijn Cox is the founder of Xeltis BV, founded in 2007, and Xeltis AG, founded in 2006, where he holds the title of Chief Technology Officer.
He has a graduate and doctorate degree from TiasNimbas Business School BV.
Postes actifs de Martijn Cox
| Sociétés | Poste | Début |
|---|---|---|
Xeltis AG
 Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Fondateur | 01/01/2006 |
Xeltis BV
 Xeltis BV Packaged SoftwareTechnology Services Xeltis BV develops self-growing heart valves out of patients tissue. The company was headquartered in Glasgow, the United Kingdom. The company was founded on November 20, 2007 by Mirjam Rubbens and Martijn Cox and is headquartered in Eindhoven, the Netherlands. | Fondateur | 20/11/2007 |
Formation de Martijn Cox
| TiasNimbas Business School BV | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Health Technology |
Xeltis BV
Xeltis BV Packaged SoftwareTechnology Services Xeltis BV develops self-growing heart valves out of patients tissue. The company was headquartered in Glasgow, the United Kingdom. The company was founded on November 20, 2007 by Mirjam Rubbens and Martijn Cox and is headquartered in Eindhoven, the Netherlands. | Technology Services |
